Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial
DOI: 10.1093/neuonc/now311
Bas Jasperse,
Bronno van der Holt,
Jan Buter,
Jan Cees de Groot,
Laurens Victor Beerepoot,
Maaike Vos,
Marion Smits,
Martin van den Bent,
Monique Hanse,
Renske Gahrmann,
René Michel Vernhout,
Walter Taal,
Zwenneke Hendrieke Flach
Keywords: bevacizumab, RANO, recurrent glioblastoma, volumetry
Abstract:
Full-Text
